Viral vector-mediated overexpression of α-synuclein as a progressive model of Parkinson's disease
(2010) In Progress in Brain Research 184. p.89-111- Abstract
The discovery of the role of α-synuclein in the pathogenesis of Parkinson's disease (PD) has opened new possibilities for the development of more authentic models of Parkinson's disease. Recombinant adeno-associated virus (AAV) and lentivirus (LV) vectors are efficient tools for expression of genes locally in subsets of neurons in the brain and can be used to express human wild-type or mutated α-synuclein selectively in midbrain dopamine neurons. Using this approach, it is possible to trigger extensive PD-like cellular and axonal pathologies in the nigrostriatal projection, involving abnormal protein aggregation, neuronal dysfunction, and cell death that develop progressively over time. Targeted overexpression of human α-synuclein in... (More)
The discovery of the role of α-synuclein in the pathogenesis of Parkinson's disease (PD) has opened new possibilities for the development of more authentic models of Parkinson's disease. Recombinant adeno-associated virus (AAV) and lentivirus (LV) vectors are efficient tools for expression of genes locally in subsets of neurons in the brain and can be used to express human wild-type or mutated α-synuclein selectively in midbrain dopamine neurons. Using this approach, it is possible to trigger extensive PD-like cellular and axonal pathologies in the nigrostriatal projection, involving abnormal protein aggregation, neuronal dysfunction, and cell death that develop progressively over time. Targeted overexpression of human α-synuclein in midbrain dopamine neurons, using AAV vectors, reproduces many of the characteristic features of the human disease and provides, for the first time, a model of progressive PD that can be applied to both rodents and primates.
(Less)
- author
- Ulusoy, Ayse
LU
; Decressac, Mickael
LU
; Kirik, Deniz
LU
and Björklund, Anders LU
- organization
- publishing date
- 2010
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Synuclein, Dopamine, Nigrostriatal system, Motor impairment, Adeno-associated virus, Lentivirus, Viral vectors, Animal models
- in
- Progress in Brain Research
- volume
- 184
- pages
- 23 pages
- publisher
- Elsevier
- external identifiers
-
- wos:000287856300006
- scopus:77957224859
- pmid:20887871
- ISSN
- 1875-7855
- DOI
- 10.1016/S0079-6123(10)84005-1
- language
- English
- LU publication?
- yes
- id
- 084e1107-2d8f-4fce-bb2d-3425f6845593 (old id 1859368)
- date added to LUP
- 2016-04-01 14:31:51
- date last changed
- 2025-01-31 04:41:51
@article{084e1107-2d8f-4fce-bb2d-3425f6845593, abstract = {{<p>The discovery of the role of α-synuclein in the pathogenesis of Parkinson's disease (PD) has opened new possibilities for the development of more authentic models of Parkinson's disease. Recombinant adeno-associated virus (AAV) and lentivirus (LV) vectors are efficient tools for expression of genes locally in subsets of neurons in the brain and can be used to express human wild-type or mutated α-synuclein selectively in midbrain dopamine neurons. Using this approach, it is possible to trigger extensive PD-like cellular and axonal pathologies in the nigrostriatal projection, involving abnormal protein aggregation, neuronal dysfunction, and cell death that develop progressively over time. Targeted overexpression of human α-synuclein in midbrain dopamine neurons, using AAV vectors, reproduces many of the characteristic features of the human disease and provides, for the first time, a model of progressive PD that can be applied to both rodents and primates.</p>}}, author = {{Ulusoy, Ayse and Decressac, Mickael and Kirik, Deniz and Björklund, Anders}}, issn = {{1875-7855}}, keywords = {{Synuclein; Dopamine; Nigrostriatal system; Motor impairment; Adeno-associated virus; Lentivirus; Viral vectors; Animal models}}, language = {{eng}}, pages = {{89--111}}, publisher = {{Elsevier}}, series = {{Progress in Brain Research}}, title = {{Viral vector-mediated overexpression of α-synuclein as a progressive model of Parkinson's disease}}, url = {{http://dx.doi.org/10.1016/S0079-6123(10)84005-1}}, doi = {{10.1016/S0079-6123(10)84005-1}}, volume = {{184}}, year = {{2010}}, }